Abstract
Two recent studies have investigated the prevalence of anti-hLAMP.-2 antibodies in patients with antineutrophil cytoplasmic antibody-associated vasculitides. Results from these studies suggest that more work is needed to standardize the assays used to detect anti-hLAMP.-2 antibodies in patient sera before we can estimate their true prevalence in different patient populations and assess their potential clinical utility.
Original language | English (US) |
---|---|
Pages (from-to) | 318-320 |
Number of pages | 3 |
Journal | Nature Reviews Nephrology |
Volume | 8 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2012 |
ASJC Scopus subject areas
- Nephrology